Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Keros Therapeutics, Inc. | 40,000 | reported | 13 Feb 2024 | tx 4+190,000 |
| Morphic Holding, Inc. | 0 | reported | 16 Aug 2024 | tx 6+191,000−191,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Aug 2024 | OTHER | Morphic Holding, Inc. | 170,000 | — | deriv |
| 16 Aug 2024 | OTHER | Morphic Holding, Inc. | 14,000 | — | deriv |
| 16 Aug 2024 | OTHER | Morphic Holding, Inc. | 7,000 | — | deriv |
| 18 Mar 2024 | GRANT_AWARD | Morphic Holding, Inc. | 170,000 | 0.00 USD | deriv |
| 18 Mar 2024 | GRANT_AWARD | Morphic Holding, Inc. | 7,000 | 0.00 USD | deriv |
| 18 Mar 2024 | GRANT_AWARD | Morphic Holding, Inc. | 14,000 | 0.00 USD | deriv |
| 13 Feb 2024 | GRANT_AWARD | Keros Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 16 Feb 2023 | GRANT_AWARD | Keros Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 21 Jan 2022 | GRANT_AWARD | Keros Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 10 Aug 2021 | GRANT_AWARD | Keros Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |